Combinatorial chemistry in drug discovery

被引:199
作者
Liu, Ruiwu [1 ,2 ]
Li, Xiaocen [1 ,2 ]
Lam, Kit S. [1 ,2 ,3 ]
机构
[1] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Dept Internal Med, Div Hematol & Oncol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
ENCODED CHEMICAL LIBRARIES; SMALL-MOLECULE LIBRARIES; UNNATURAL AMINO-ACIDS; SOLID-PHASE SYNTHESIS; IN-VITRO; MACROCYCLIC PEPTIDES; BICYCLIC PEPTIDES; GENERAL-METHOD; INHIBITORS; DESIGN;
D O I
10.1016/j.cbpa.2017.03.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several combinatorial methods have been developed to create focused or diverse chemical libraries with a wide range of linear or macrocyclic chemical molecules: peptides, non-peptide oligomers, peptidomimetics, small-molecules, and natural product-like organic molecules. Each combinatorial approach has its own unique high-throughput screening and encoding strategy. In this article, we provide a brief overview of combinatorial chemistry in drug discovery with emphasis on recently developed new technologies for design, synthesis, screening and decoding of combinatorial library. Examples of successful application of combinatorial chemistry in hit discovery and lead optimization are given. The limitations and strengths of combinatorial chemistry are also briefly discussed. We are now in a better position to truly leverage the power of combinatorial technologies for the discovery and development of next-generation drugs.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 69 条
[1]   Iterative In Situ Click Chemistry Creates Antibody-like Protein-Capture Agents [J].
Agnew, Heather D. ;
Rohde, Rosemary D. ;
Millward, Steven W. ;
Nag, Arundhati ;
Yeo, Woon-Seok ;
Hein, Jason E. ;
Pitram, Suresh M. ;
Tariq, Abdul Ahad ;
Burns, Vanessa M. ;
Krom, Russell J. ;
Fokin, Valery V. ;
Sharpless, K. Barry ;
Heath, James R. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (27) :4944-4948
[2]   From combinatorial chemistry to cancer-targeting peptides [J].
Aina, Olulanu H. ;
Liu, Ruiwu ;
Sutcliffe, Julie L. ;
Marik, Jan ;
Pan, Chong-Xian ;
Lam, Kit S. .
MOLECULAR PHARMACEUTICS, 2007, 4 (05) :631-651
[3]  
Aquino C, 2012, NAT CHEM, V4, P99, DOI [10.1038/NCHEM.1200, 10.1038/nchem.1200]
[4]   Multiple-component condensation strategies for combinatorial library synthesis [J].
Armstrong, RW ;
Combs, AP ;
Tempest, PA ;
Brown, SD ;
Keating, TA .
ACCOUNTS OF CHEMICAL RESEARCH, 1996, 29 (03) :123-131
[5]   Biosynthesis and Biological Screening of a Genetically Encoded Library Based on the Cyclotide MCoTI-I [J].
Austin, Jeffrey ;
Wang, Wan ;
Puttamadappa, Swamy ;
Shekhtman, Alexander ;
Camarero, Julio A. .
CHEMBIOCHEM, 2009, 10 (16) :2663-2670
[6]   Fragment-based lead discovery grows up [J].
Baker, Monya .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (01) :5-10
[7]   Liquid-Phase Combinatorial Library Synthesis: Recent Advances and Future Perspectives [J].
Barot, Kuldipsinh P. ;
Nikolova, Stoyanka ;
Ivanov, Illiyan ;
Ghate, Manjunath D. .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2014, 17 (05) :417-438
[8]   Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies [J].
Bashiruddin, Nasir K. ;
Suga, Hiroaki .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2015, 24 :131-138
[9]   Fidelity by design: Yoctoreactor and binder trap enrichment for small-molecule DNA-encoded libraries and drug discovery [J].
Blakskjaer, Peter ;
Heitner, Tara ;
Hansen, Nils Jakob Vest .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2015, 26 :62-71
[10]   Vemurafenib: the first drug approved for BRAF-mutant cancer [J].
Bollag, Gideon ;
Tsai, James ;
Zhang, Jiazhong ;
Zhang, Chao ;
Ibrahim, Prabha ;
Nolop, Keith ;
Hirth, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (11) :873-886